Integrated Wealth Concepts’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $547K | Sell |
4,353
-2,880
| -40% | -$362K | 0.01% | 1221 |
|
|
2025
Q1 | $800K | Buy |
7,233
+4,526
| +167% | +$501K | 0.01% | 923 |
|
|
2024
Q4 | $370K | Buy |
2,707
+757
| +39% | +$103K | ﹤0.01% | 1261 |
|
|
2024
Q3 | $225K | Sell |
1,950
-143
| -7% | -$16.5K | ﹤0.01% | 1506 |
|
|
2024
Q2 | $288K | Sell |
2,093
-1
| -0% | -$138 | ﹤0.01% | 1341 |
|
|
2024
Q1 | $289K | Buy |
2,094
+34
| +2% | +$4.69K | ﹤0.01% | 1340 |
|
|
2023
Q4 | $271K | Buy |
2,060
+10
| +0.5% | +$1.32K | ﹤0.01% | 1315 |
|
|
2023
Q3 | $231K | Buy |
+2,050
| New | +$231K | ﹤0.01% | 1347 |
|